“A Shocking Presentation: Pressing Forward with Angiotensin II”
HealthTrust presents…”A Shocking Presentation: Pressing Forward with Angiotensin II”
The Surviving Sepsis Campaign updated its guidelines in 2016 to include use of the sequential organ failure assessment (SOFA) score rather than the systemic inflammatory response syndrome (SIRS) criteria. Most hospitals and physicians still utilize the SIRS criteria in distinguishing the severity of sepsis. In 2017, human angiotensin II was approved for use in the United States based on the results of the phase 3 Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) trial.
While its use has not grown substantially since approval, there is discussion regarding its place in therapy and when to use it. The presenter will review the 2016 sepsis guidelines, discuss vasopressors in greater detail, and explain the potential role of angiotensin II in therapy. The session will also cover the potential considerations and cautions of using angiotensin II in practice. Because its use will become more common over time, it is important for licensed pharmacists to understand the new pressor, relevant updates and have an awareness of how angiotensin II could fit into the current guideline recommendations.
Learning Objectives for Pharmacists | At the end of this session, participants should be able to:
- Describe the etiology and current treatment guidelines for septic shock
- Discuss the various vasoactive agents and their places in septic shock
- Review the evidence and background of angiotensin II
- Evaluate the role of angiotensin II in therapy
Learning Objectives for Pharmacy Technicians | At the end of this session, participants should be able to:
- Describe the presentation of a patient in septic shock
- List guideline recommendations for treatment of septic shock
- Review preparation and storage instructions for angiotensin II
Sophia Pathan, PharmD | PGY-1 Pharmacy Resident | Overlook Medical Center
Target Audience: Pharmacists & Pharmacy Techs
Continuing Education Information: 1.0 contact hours for Pharmacists and Pharmacy Technicians. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Numbers for this activity are 0863-9999-19-035-L04-P and 0863-9999-19-035-L04-T. The activity will provide 1 hour (.1 CEUs) of continuing education credit to pharmacists who attend the webinar and complete the online evaluation.
Note about CE credit: If you plan to obtain credit, stay until the end of the presentation to receive the verification code you will need to obtain your continuing education credit. A reminder that CE credit is individual. No group credit is available. Each person must register for this session and attend the webinar for 40 minutes or longer in order to receive an email after the event with instructions on how to apply for continuing education credit. Please do not share the code or forward the email you receive to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. Also, please note: If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.